User research in product development in business to business software as a service

Customers are more empowered to make purchasing decisions than ever before, and customer experience has become a critical decision factor. Business to business (B2B) software as a service (SaaS) companies are changing their strategies and ways of working to become more customer-centric and stay competitive. To understand users, their needs, motivations and the problems that they are facing, companies do user research and involve users in product development. This thesis explores how B2B SaaS organizations utilize user research when developing products. It aims to answer some of the most fundamental questions: which user research methods companies use, how they involve internal stakeholders in user research and how they select the users and motivate them to take part in product development. A qualitative multiple case study approach was used in this thesis to answer the research questions. The literature review aims to provide a broad overview of the topic. Six B2B SaaS companies and two service design companies were interviewed to learn about user research in B2B SaaS field. The results of the thesis show that less customer-centric organizations do ad-hoc user research. More customer-centric companies incorporate user research into the development process. Both approaches are valuable for developing a product that fits customer needs but incorporated user involvement is necessary for achieving a better outcome. Customer-centric organizations include various stakeholders in user research to increase the transparency of findings and create empathy towards users. Furthermore, qualitative user research is essential for customer-centric product development. Regarding the users, while they are motivated to take part in product development, it was discovered that in the B2B field the process of approaching users can be challenging. This thesis compares how different B2B SaaS companies do user research. It reveals the best practices, challenges and opportunities of user involvement. This information can be useful for organizations that aim to become customer-centric. The findings contribute to the literature by providing insights into successful examples and the challenges of user involvement in product development in B2B SaaS organizations

Economic Mechanisms of Management of Socio-Ecological Systems’ Sustainability

The purpose of the article is to develop perspective economic mechanisms of management of socio-ecological systems’ sustainability. In order to achieve this goal, the authors use the method of correlation and regression analysis, scenario analysis, method of modeling and forecasting, as well as methods of systemic and problem analysis, synthesis, induction, deduction, and graphic and table representation of information. In the process of the research, the authors determine the essence of socio-ecological systems’ sustainability, study the contradiction of interests of society’s development and protection of the environment. For realization of the set tasks, the authors determine the current state of socio-ecological systems from the point of view of balance of these interests and analyze the connection between economic and ecological indicators of the countries’ development. A tool for confirming the offered hypothesis is calculation of correlation of ecological effectiveness index and gross internal products. As a result of the research, the authors come to the conclusion that economic reasons are the main ones for emergence and aggravation of the problem of harmonic and sustainable development of socio-ecological systems; thus, economic tools are required for solving this problem. The authors offer perspective mechanisms of management of sustainability of modern socio-ecological systems and view scenarios of future development of events in the sphere of management of sustainability of socio-ecological systems

Dark‑adaptation in the eyes of a lake and a sea population of opossum shrimp (Mysis relicta): retinoid isomer dynamics, rhodopsin regeneration, and recovery of light sensitivity

We have studied dark-adaptation at three levels in the eyes of the crustaceanMysis relictaover 2-3 weeks after exposing initially dark-adapted animals to strong white light: regeneration of 11-cisretinal through the retinoid cycle (by HPLC), restoration of native rhodopsin in photoreceptor membranes (by MSP), and recovery of eye photosensitivity (by ERG). We compare two model populations ("Sea", S-p, and "Lake", L-p) inhabiting, respectively, a low light and an extremely dark environment. 11-cisretinal reached 60-70% of the pre-exposure levels after 2 weeks in darkness in both populations. The only significant L-p/S(p)difference in the retinoid cycle was that L(p)had much higher levels of retinol, both basal and light-released. In S-p, rhodopsin restoration and eye photoresponse recovery parallelled 11-cisretinal regeneration. In L-p, however, even after 3 weeks only ca. 25% of the rhabdoms studied had incorporated new rhodopsin, and eye photosensitivity showed only incipient recovery from severe depression. The absorbance spectra of the majority of the L(p)rhabdoms stayed constant around 490-500 nm, consistent with metarhodopsin II dominance. We conclude that sensitivity recovery of S(p)eyes was rate-limited by the regeneration of 11-cisretinal, whilst that of L(p)eyes was limited by inertia in photoreceptor membrane turnover.Peer reviewe

The Right Tool for the Job: Detection of Soil-Transmitted Helminths in Areas Co-endemic for Other Helminths

Due to the recent increased use of the McMaster (MM) fecal egg counting method for assessing benzimidazole drug efficacy for treating soil-transmitted helminth (STH) infections, the aim of the current study was to determine the operational value of including the MM method alongside the Kato-Katz (KK) fecal thick smear to increase the diagnostic sensitivity when STHs are co-endemic with trematode helminths (e.g., Schistosoma mansoni). Methods A cross-sectional study was conducted in school-aged children aged 4-18 years in the northeastern region of the State of Minas Gerais (Brazil), where Necator americanus, Ascaris lumbricoides, Trichuris trichiura, and S. mansoni are co-endemic. One fecal sample from each participant was collected and transported to the field laboratory for analysis. Coprological diagnosis was performed on each fecal sample by three different methods: Formalin-Ether Sedimentation (FES), KK and the MM technique. The diagnostic sensitivity and negative predictive value (NPV) of each technique was calculated using the combination of all three techniques as the composite standard. In order to determine the agreement between the three techniques Fleiss´ kappa was used. Both the Cure Rate (CR) and the Fecal Egg Count Reduction (FECR) were calculated using the two quantification techniques (i.e., the MM and KK). Results Fecal samples from 1260 children were analyzed. The KK had higher diagnostic sensitivity than the MM for the detection of both A. lumbricoides (KK 97.3%, MM 69.5%) and hookworm (KK 95.1%, MM 80.8%). The CR of a single dose of mebendazole varied significantly between the KK and MM for both A. lumbricoides (p = 0.016) and hookworm (p = 0.000), with lower rates obtained with the KK. On the other hand, the FECR was very similar between both techniques for both A. lumbricoides and hookworm. Conclusion The MM did not add any diagnostic value over the KK in areas where both STHs and trematodes were co-endemic. The lower sensitivity of the MM would have an important impact on the administration of selective school-based treatment in this area since if only the MM were used, 36 (13.9%) children diagnosed with A. lumbricoides would have gone untreated. Author Summary Diagnosis of intestinal helminths and Schistosoma mansoni infections is based on the detection of eggs in feces. There are many techniques available for both detection and quantification of infection. For the quantification of helminth infections, the methods traditionally used are the Kato-Katz (KK) fecal think smear in humans, and the McMaster (MM) counting method in animals. Recently, the MM has been used for assessing the efficacy of benzimidazole drugs for treating soil-transmitted helminth (STH) infections in humans. In most parts of the world, however, STHs occur simultaneously with other helminth species, and the MM does not detect other helminth eggs. Therefore, in this study we sought to determine if the use of the MM in an area of Brazil were both STHs and S. mansoni are co-endemic, added any value to the current standard of diagnosis using the KK

Mercury pollution for marine environment at Farwa Island, Libya

Coimmobilization of pyranose dehydrogenase as an enzyme catalyst, osmium redox polymers [Os­(4,4′-dimethoxy-2,2′-bipyridine)₂(poly­(vinylimidazole))₁₀Cl]⁺ or [Os­(4,4′-dimethyl-2,2′-bipyridine)₂(poly­(vinylimidazole))₁₀Cl]⁺ as mediators, and carbon nanotube conductive scaffolds in films on graphite electrodes provides enzyme electrodes for glucose oxidation. The recombinant enzyme and a deglycosylated form, both expressed in Pichia pastoris, are investigated and compared as biocatalysts for glucose oxidation using flow injection amperometry and voltammetry. In the presence of 5 mM glucose in phosphate-buffered saline (PBS) (50 mM phosphate buffer solution, pH 7.4, with 150 mM NaCl), higher glucose oxidation current densities, 0.41 mA cm^–2, are obtained from enzyme electrodes containing the deglycosylated form of the enzyme. The optimized glucose-oxidizing anode, prepared using deglycosylated enzyme coimmobilized with [Os­(4,4′-dimethyl-2,2′-bipyridine)₂(poly­(vinylimidazole))₁₀Cl]⁺ and carbon nanotubes, was coupled with an oxygen-reducing bilirubin oxidase on gold nanoparticle dispersed on gold electrode as a biocathode to provide a membraneless fully enzymatic fuel cell. A maximum power density of 275 μW cm^–2 is obtained in 5 mM glucose in PBS, the highest to date under these conditions, providing sufficient power to enable wireless transmission of a signal to a data logger. When tested in whole human blood and unstimulated human saliva maximum power densities of 73 and 6 μW cm^–2 are obtained for the same fuel cell configuration, respectively

Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults

Necator americanus Glutathione-S-Transferase-1 (Na-GST-1) plays a role in the digestion of host hemoglobin by adult N. americanus hookworms. Vaccination of laboratory animals with recombinant Na-GST-1 is associated with significant protection from challenge infection. Recombinant Na-GST-1 was expressed in Pichia pastoris and adsorbed to aluminum hydroxide adjuvant (Alhydrogel) according to current Good Manufacturing Practice. Two Phase 1 trials were conducted in 142 healthy adult volunteers in the United States and Brazil, first in hookworm-naïve individuals and then in residents of a N. americanus endemic area in Brazil. Volunteers received one of three doses of recombinant Na-GST-1 (10, 30, or 100 μg) adjuvanted with Alhydrogel, adjuvanted with Alhydrogel and co-administered with an aqueous formulation of Glucopyranosyl Lipid A (GLA-AF), or the hepatitis B vaccine. Vaccinations were administered via intramuscular injection on days 0, 56, and 112. Na-GST-1/Alhydrogel was well tolerated in both hookworm-naïve and hookworm-exposed adults, with the most common adverse events being mild to moderate injection site pain and tenderness, and mild headache and nausea; no vaccine-related severe or serious adverse events were observed. Antigen-specific IgG antibodies were induced in a dose-dependent fashion, with increasing levels observed after each vaccination in both trials. The addition of GLA-AF to Na-GST-1/Alhydrogel did not result in significant increases in specific IgG responses. In both the US and Brazil studies, the predominant IgG subclass induced against Na-GST-1 was IgG1, with lesser amounts of IgG3. Vaccination of both hookworm-naïve and hookworm-exposed adults with recombinant Na-GST-1 was safe, well tolerated, and resulted in significant antigen-specific IgG responses. Based on these results, this vaccine will be advanced into clinical trials in children and eventual efficacy studies.Fil: Diemert, David J.. The George Washington University; Estados UnidosFil: Freire, Janaína. Fundación Oswaldo Cruz; BrasilFil: Vanderson, Valente. Fundación Oswaldo Cruz; BrasilFil: Talles, Federico. Fundación Oswaldo Cruz; BrasilFil: Grahek, Shannon. The George Washington University; Estados UnidosFil: Campbell, Doreen. The George Washington University; Estados UnidosFil: Jariwala, Amar. The George Washington University; Estados UnidosFil: Periago, Maria Victoria. Fundación Oswaldo Cruz; Brasil. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Enk, Martin. Fundación Oswaldo Cruz; BrasilFil: Gazzinelli, María Flavia. Universidade Federal do Minas Gerais; BrasilFil: Bottazzi, María Elena. Baylor College of Medicine; Estados UnidosFil: Hamilton, Roberto. University Johns Hopkins; Estados UnidosFil: Brelsford, Jill. The George Washington University; Estados UnidosFil: Yakovleva, Anna. The George Washington University; Estados UnidosFil: Guangzhao, Li. The George Washington University; Estados UnidosFil: Peng, Jin. The George Washington University; Estados UnidosFil: Correa Oliveira, Rodrigo. Fundación Oswaldo Cruz; BrasilFil: Hotez, Peter. Baylor College of Medicine; Estados UnidosFil: Bethony, Jeffrey. The George Washington University; Estados Unido

Cerebrovascular complications of hematopoetic stem cell transplantation in patients with hematologic malignancies

Introduction. Modern transplantation and biological therapy methods are associated with a wide range of adverse events and complications. Incidence and variety of neurological complications mostly depend on myelo- and immunosuppression severity and duration as well as on donor's and recipient's characteristics. The most frequent complications involving the nervous system include neurotoxic reactions, infections, autoimmune and lymphoproliferative diseases, and dysmetabolic conditions as well as cerebrovascular complications that potentially affect transplantation outcomes. Objective. To evaluate the impact of post-transplantation cerebrovascular events (CVEs) on transplantation outcomes in patients with hematologic malignancies. Materials and methods. We analyzed 899 transplantations performed at the Raisa Gorbacheva Memorial Research Institute for Pediatric Oncology, Hematology, and Transplantation, Pavlov First Saint Petersburg State Medical University, from 2016 to 2018. We assessed transplantation parameters and donor's and recipient's characteristics by intergroup comparison, pseudo-randomization (propensity score matching), KaplanMeier survival analysis, and log-rank tests. Results. Post-transplantatively, CVEs developed in 2.6% (n = 23) of cases: 13 (1.4%) ischemic strokes and 11 (1.2%) hemorrhagic strokes or intracranial hemorrhages were diagnosed. CVEs developed on days 99.5 39.2 post hematopoetic stem cell transplantation (HSCT). There were more patients with non-malignant conditions in the CVE group as compared to the non-CVE group (21.7% vs 7.9%; p = 0.017). Patients with CVE had a significantly lower Karnofsky index (75.6 21.3 vs 85.2 14.9; p = 0.008). Statistically, we also note some non-significant trends: patients with CVE more often underwent allogenic HSCT (82.6% vs 64.0%; p = 0.077) while donors were more often partially (rather than totally) HLA compatible for recipients (39.1% vs 21.1%; p = 0.33). Patients with CVE more often had a history of venous thromboses (13.3% vs 4.2%; p = 0.077). Post-HSCT stroke decreased post-transplantation longevity by approximately 3 times (331.8 81.6 vs 897.9 25.4 post HSCT; p = 0.0001). In the CVE group, survival during first 180 days post HSCT (landmarks post-HSCT Day+60 and Day+180) was significantly lower as compared to that in the CVE-free group. If CVE developed during first 30 days and 100 days post HSCT, vascular catastrophe did not affect post-HSCT survival significantly. Conclusion. Whereas ischemic stroke is a long-term HSCT complication (beyond D+100 post transplantation), hemorrhagic stroke is a short-term complication (D0D+100 post HSCT). CVEs affect survival in patients with hematologic malignancies, especially those developed between D+60 and D+180 post HSCT. History of venous abnormalities, low Karnofsky index at HSCT initiation, and the type of allogenic HSCT, especially from half-matched donors, can be considered as negative outcome risk factors in post-HSCT CVE

Comparative analysis of IgG levels in blood sera from patients with COVID-19, persons vaccinated by «Gam-COVID-Vac» and healthy donors before the pandemic

Introduction. Serum IgG measurement is used in the diagnosis and monitoring of many diseases. Therefore, it seems important to study the impact of coronavirus pandemic on IgG levels in population and the role of this parameter in COVID-19. The aim of this study was to compare mean IgG levels in sera obtained from 31 hospitalized COVID-19 patients, 30 healthy donors before pandemic and 34 donors vaccinated with «Sputnik V» (have not had COVID-19). Materials and methods. Total IgG was quantitated by two enzyme immunoassays (EIAs): «IgG Total-ELISA-BEST» kit certificated in Russia and homemade competitive EIA utilizing bispecific monoclonal antibodies (bsAbs) against human IgG (HIgG) and horseradish peroxidase (HRP). Results and discussion. The groups did not show differences in IgG levels (regardless of sex) with both methods giving comparable results. However, «IgG Total-ELISA-BEST» kit revealed statistically significant differences in mean serum IgG levels in subgroups of male patients depending on the levels of antibodies to viral RBD-antigen: below and above 400 BAU/ml. In the first subgroup (10 men) the mean serum IgG content was 14.3 ± 4.1 mg/mL, while in the second (6 men) — 6.9 ± 2.7 mg/mL. Conclusion. Sera obtained before pandemic contained the same mean IgG concentrations as sera from donors vaccinated with «Sputnik V» and COVID-19 patients. The relatively decreased mean IgG concentration was found only in COVID-19 male patients with anti-RBD antibodies levels above 400 BAU/ml. In light of literature data on association of decreased serum IgG with COVID-19 severity, it would be reasonable to further compare larger groups, taking into account clinical differences. The possibility of using bsAbs for human Ig measurements by competitive EIA was demonstrated

Tracking the Small with the Smallest – Using Nanotechnology in Tracking Zooplankton

A major problem when studying behavior and migration of small organisms is that many of the questions addressed for larger animals are not possible to formulate due to constraints on tracking smaller animals. In aquatic ecosystems, this problem is particularly problematic for zoo- and phytoplankton, since tracking devices are too heavy to allow the organism to act naturally. However, recent advances in nanotechnology have made it possible to track individual animals and thereby to focus on important and urgent questions which previously have not been possible to address. Here we report on a novel approach to track movement and migratory behavior of millimeter sized aquatic animals, particularly Daphnia magna, using the commercially available nanometer sized fluorescent probes known as quantum dots. Experimental trials with and without quantum dots showed that they did not affect behavior, reproduction or mortality of the tested animals. Compared to previously used methods to label small animals, the nano-labeling method presented here offers considerable improvements including: 24 h fluorescence, studies in both light and darkness, much improved optical properties, potential to study large volumes and even track animals in semi-natural conditions. Hence, the suggested method, developed in close cooperation between biologists, chemists and physicists, offers new opportunities to routinely study zooplankton responses to light, food and predation, opening up advancements within research areas such as diel vertical/horizontal migration, partial migration and other differences in intra- and interspecific movements and migration

Correlation of histopathologic characteristics to protein expression and function in malignant melanoma

BACKGROUND: Metastatic melanoma is still one of the most prevalent skin cancers, which upon progression has neither a prognostic marker nor a specific and lasting treatment. Proteomic analysis is a versatile approach with high throughput data and results that can be used for characterizing tissue samples. However, such analysis is hampered by the complexity of the disease, heterogeneity of patients, tumors, and samples themselves. With the long term aim of quest for better diagnostics biomarkers, as well as predictive and prognostic markers, we focused on relating high resolution proteomics data to careful histopathological evaluation of the tumor samples and patient survival information. PATIENTS AND METHODS: Regional lymph node metastases obtained from ten patients with metastatic melanoma (stage III) were analyzed by histopathology and proteomics using mass spectrometry. Out of the ten patients, six had clinical follow-up data. The protein deep mining mass spectrometry data was related to the histopathology tumor tissue sections adjacent to the area used for deep-mining. Clinical follow-up data provided information on disease progression which could be linked to protein expression aiming to identify tissue-based specific protein markers for metastatic melanoma and prognostic factors for prediction of progression of stage III disease. RESULTS: In this feasibility study, several proteins were identified that positively correlated to tumor tissue content including IF6, ARF4, MUC18, UBC12, CSPG4, PCNA, PMEL and MAGD2. The study also identified MYC, HNF4A and TGFB1 as top upstream regulators correlating to tumor tissue content. Other proteins were inversely correlated to tumor tissue content, the most significant being; TENX, EHD2, ZA2G, AOC3, FETUA and THRB. A number of proteins were significantly related to clinical outcome, among these, HEXB, PKM and GPNMB stood out, as hallmarks of processes involved in progression from stage III to stage IV disease and poor survival. CONCLUSION: In this feasibility study, promising results show the feasibility of relating proteomics to histopathology and clinical outcome, and insight thus can be gained into the molecular processes driving the disease. The combined analysis of histological features including the sample cellular composition with protein expression of each metastasis enabled the identification of novel, differentially expressed proteins. Further studies are necessary to determine whether these putative biomarkers can be utilized in diagnostics and prognostic prediction of metastatic melanoma